|
A new study has validated a diagnostic test developed for
melanoma, called Merlin, that combines a patient's genetic information
from a skin biopsy with other characteristics to show whether they are
at risk of their cancer spreading. The goal is to reduce unnecessary
biopsy surgeries.
|
No comments:
Post a Comment